Cargando…

Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience

Hematopathologists are witnessing very exciting times, as a new era of unsurpassed technological advances is unfolding exponentially, enhancing our understanding of diseases at the genomic and molecular levels. In the evolving field of precision medicine, our contributions as hematopathologists to m...

Descripción completa

Detalles Bibliográficos
Autores principales: El Hussein, Siba, Khoury, Joseph D., Lyapichev, Kirill A., Tashakori, Mehrnoosh, Khanlari, Mahsa, Miranda, Roberto N., Kanagal-Shamanna, Rashmi, Wang, Sa A., Ahmed, Aadil, Mirza, Kamran M., Crane, Genevieve M., Medeiros, L. Jeffrey, Loghavi, Sanam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678590/
https://www.ncbi.nlm.nih.gov/pubmed/33219298
http://dx.doi.org/10.1038/s41379-020-00715-4
_version_ 1783612188849602560
author El Hussein, Siba
Khoury, Joseph D.
Lyapichev, Kirill A.
Tashakori, Mehrnoosh
Khanlari, Mahsa
Miranda, Roberto N.
Kanagal-Shamanna, Rashmi
Wang, Sa A.
Ahmed, Aadil
Mirza, Kamran M.
Crane, Genevieve M.
Medeiros, L. Jeffrey
Loghavi, Sanam
author_facet El Hussein, Siba
Khoury, Joseph D.
Lyapichev, Kirill A.
Tashakori, Mehrnoosh
Khanlari, Mahsa
Miranda, Roberto N.
Kanagal-Shamanna, Rashmi
Wang, Sa A.
Ahmed, Aadil
Mirza, Kamran M.
Crane, Genevieve M.
Medeiros, L. Jeffrey
Loghavi, Sanam
author_sort El Hussein, Siba
collection PubMed
description Hematopathologists are witnessing very exciting times, as a new era of unsurpassed technological advances is unfolding exponentially, enhancing our understanding of diseases at the genomic and molecular levels. In the evolving field of precision medicine, our contributions as hematopathologists to medical practice are of paramount importance. Social media platforms such as Twitter have helped facilitate and enrich our professional  interactions and collaborations with others in our field and in other medical disciplines leading to a more holistic approach to patient care. These platforms also have created a novel means for instantaneous dissemination of new findings and recent publications, and are proving to be increasingly useful tools that can be harnessed to expand our knowledge and amplify our presence in the medical community. In this Editorial, we share our experience as hematopathologists with Twitter, and how we leveraged this platform to boost scholarly activities within and beyond our subspecialty, and as a powerful medium for worldwide dissemination of educational material and to promote our remote teaching activities during the COVID-19 pandemic.
format Online
Article
Text
id pubmed-7678590
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-76785902020-11-23 Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience El Hussein, Siba Khoury, Joseph D. Lyapichev, Kirill A. Tashakori, Mehrnoosh Khanlari, Mahsa Miranda, Roberto N. Kanagal-Shamanna, Rashmi Wang, Sa A. Ahmed, Aadil Mirza, Kamran M. Crane, Genevieve M. Medeiros, L. Jeffrey Loghavi, Sanam Mod Pathol Editorial Hematopathologists are witnessing very exciting times, as a new era of unsurpassed technological advances is unfolding exponentially, enhancing our understanding of diseases at the genomic and molecular levels. In the evolving field of precision medicine, our contributions as hematopathologists to medical practice are of paramount importance. Social media platforms such as Twitter have helped facilitate and enrich our professional  interactions and collaborations with others in our field and in other medical disciplines leading to a more holistic approach to patient care. These platforms also have created a novel means for instantaneous dissemination of new findings and recent publications, and are proving to be increasingly useful tools that can be harnessed to expand our knowledge and amplify our presence in the medical community. In this Editorial, we share our experience as hematopathologists with Twitter, and how we leveraged this platform to boost scholarly activities within and beyond our subspecialty, and as a powerful medium for worldwide dissemination of educational material and to promote our remote teaching activities during the COVID-19 pandemic. Nature Publishing Group US 2020-11-20 2021 /pmc/articles/PMC7678590/ /pubmed/33219298 http://dx.doi.org/10.1038/s41379-020-00715-4 Text en © The Author(s), under exclusive licence to United States & Canadian Academy of Pathology 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Editorial
El Hussein, Siba
Khoury, Joseph D.
Lyapichev, Kirill A.
Tashakori, Mehrnoosh
Khanlari, Mahsa
Miranda, Roberto N.
Kanagal-Shamanna, Rashmi
Wang, Sa A.
Ahmed, Aadil
Mirza, Kamran M.
Crane, Genevieve M.
Medeiros, L. Jeffrey
Loghavi, Sanam
Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience
title Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience
title_full Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience
title_fullStr Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience
title_full_unstemmed Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience
title_short Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience
title_sort next-generation scholarship: rebranding hematopathology using twitter: the md anderson experience
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678590/
https://www.ncbi.nlm.nih.gov/pubmed/33219298
http://dx.doi.org/10.1038/s41379-020-00715-4
work_keys_str_mv AT elhusseinsiba nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT khouryjosephd nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT lyapichevkirilla nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT tashakorimehrnoosh nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT khanlarimahsa nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT mirandaroberton nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT kanagalshamannarashmi nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT wangsaa nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT ahmedaadil nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT mirzakamranm nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT cranegenevievem nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT medeirosljeffrey nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience
AT loghavisanam nextgenerationscholarshiprebrandinghematopathologyusingtwitterthemdandersonexperience